US Patent 7655621 Cross-linked glycopeptide-cephalosporin antibiotics
Patent 7655621 was granted and assigned to Theravance on February, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7655621 Cross-linked glycopeptide-cephalosporin antibiotics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
